UroGen Pharma (URGN) Other Non-Current Liabilities (2020 - 2026)
UroGen Pharma (URGN) reported Other Non-Current Liabilities of $3.9 million for Q2 2026, up 3.0% from $3.79 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
UroGen Pharma (URGN) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Dating back to Q4 2020, UroGen Pharma's Other Non-Current Liabilities record includes 23 quarters.
- Other Non-Current Liabilities has increased for five consecutive years, with a five-year compound annual growth rate of 7.5% (FY2020 to FY2025).
- By year, Other Non-Current Liabilities came in at $3.79 million in FY2024 (+18.7%), $3.19 million in FY2023 (+5.8%), $3.02 million in FY2022 (+6.2%) and $2.84 million in FY2021 (+4.6%).
- Year over year, Other Non-Current Liabilities has now increased in each of the last 19 quarters, with growth averaging 11.2% over the last eight quarters.
- Across the past five years, year-over-year growth in Other Non-Current Liabilities ran from 3.0% in Q4 2025 to 18.7% in Q3 2025.
- Per Business Quant data, the three quarters before Q2 2026 came in at $3.9 million (Q1 2026), $3.9 million (Q4 2025) and $3.79 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | UroGen Pharma | 1.24 Bn | 782.15 Mn | 81.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.90 Mn |
| Jun 30, 2026 | 3.90 Mn |
| Mar 31, 2026 | 3.90 Mn |
| Dec 31, 2025 | 3.90 Mn |
| Sep 30, 2025 | 3.79 Mn |
| Jun 30, 2025 | 3.79 Mn |
| Mar 31, 2025 | 3.79 Mn |
| Dec 31, 2024 | 3.79 Mn |
| Sep 30, 2024 | 3.19 Mn |
| Jun 30, 2024 | 3.19 Mn |
| Mar 31, 2024 | 3.19 Mn |
| Dec 31, 2023 | 3.19 Mn |
| Sep 30, 2023 | 3.02 Mn |
| Jun 30, 2023 | 3.02 Mn |
| Mar 31, 2023 | 3.02 Mn |
| Dec 31, 2022 | 3.02 Mn |
| Sep 30, 2022 | 2.84 Mn |
| Jun 30, 2022 | 2.84 Mn |
| Mar 31, 2022 | 2.84 Mn |
| Dec 31, 2021 | 2.84 Mn |
API Access
UroGen Pharma Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=URGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();